Clot wave analysis and thromboembolic score in liver cirrhosis: two opposing phenomena

International Journal of Laboratory Hematology

Volumn 39, Issue 4, 2017, Pages 369-374

  Ruberto, M F ^a   Sorbello, O ^b   Civolani, A ^b   Barcellona, D ^a   Demelia, L ^b   Marongiu, F ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

activated partial thromboplastin time derivatives; Clot waveform analysis; hemorrhage; liver cirrhosis; risk assessment; venous thrombosis

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BLOOD EXAMINATION; CLOT WAVE ANALYSIS; DISEASE PREDISPOSITION; FEMALE; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; VELOCITY; VENOUS THROMBOEMBOLISM; BLOOD; BLOOD CLOTTING TEST; COMPLICATION; HEMORRHAGE; MIDDLE AGED; PROTHROMBIN TIME; THROMBOEMBOLISM; VENOUS THROMBOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION; BLOOD COAGULATION TESTS; FEMALE; HEMORRHAGE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RISK ASSESSMENT; THROMBOEMBOLISM; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 85018578866     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/ijlh.12635     Document Type: Article

References (14)

1. Tripodi A. Liver Disease and Hemostatic (Dys)function. Semin Thromb Hemost 2015;41:462–7.
2. Buresi M, Hull R, Coffin CS. Venous thromboembolism in cirrhosis: a review of the literature. Can J Gastroenterol 2012;26:905–8.
3. Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, Primignani M, Mannucci PM. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 2005;4:553–8.
4. Amitrano L, Guardascione MA, Brancaccio V, Balzano A. Coagulation disorders in liver disease. Semin Liver Dis 2002;22:83–96.
5. White GC 2nd. The partial thromboplastin time: defining an era in coagulation. J Thromb Haemost 2003;1: 2267–70.
6. Tripodi A, Chantarangkul V, Martinelli I, Bucciarelli P, Mannucci PM. A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood 2004;104:3631–4.
7. Solano C, Zerafa P, Bird R. A study of atypical APTT derivative curves on the ACL TOP coagulation analyser. Int J Lab Hematol 2011;33:67–78.
8. Shima M, Thachil J, Nair SC, Srivastava A, Scientific and Standardization Committee. Towards standardization of clot waveform analysis and recommendations for its clinical applications. J Thromb Haemost 2013;11:1417–20.
9. Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M, De Bon E, Tormene D, Pagnan A, Prandoni P. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost 2010;8:2450–7.
10. Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA, Cook DJ, Balekian AA, Klein RC, Le H, Schulman S, Murad MH; American College of Chest Physicians. Prevention of VTE in nonsurgical patients: antithrombotic Therapy and Prevention of Thrombosis, 9th edn. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;2(Suppl):e195S–226S.
11. Shima M, Matsumoto T, Fukuda K, Kubota Y, Tanaka I, Nishiya K, Giles AR, Yoshioka A. The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia A patients with very low levels of factor VIII activity (FVIII:C). Thromb Haemost 2002;87:436–41.
12. Espitia O, Fouassier M, Hardouin JB, Pistorius MA, Agard C, Planchon B, Trossaert M, Pottier P. Thrombin generation assay in hospitalized nonsurgical patients: a new tool to assess venous thromboembolism risk? Clin Appl Thromb Hemost 2017;23:45–51.
13. Francis CW. Clinical practice. Prophylaxis for thromboembolism in hospitalized medical patients. N Engl J Med 2007;356:1438–44.
14. Rodríguez-Castro KI, Antonello A, Ferrarese A. Spontaneous bleeding or thrombosis in cirrhosis: what should be feared the most? World J Hepatol 2015;7:1818–27.